Zobrazeno 1 - 10
of 902
pro vyhledávání: '"Vanella, V"'
Autor:
Owen, C.N., Bai, X., Quah, T., Lo, S.N., Allayous, C., Callaghan, S., Martínez-Vila, C., Wallace, R., Bhave, P., Reijers, I.L.M., Thompson, N., Vanella, V., Gerard, C.L., Aspeslagh, S., Labianca, A., Khattak, A., Mandala, M., Xu, W., Neyns, B., Michielin, O., Blank, C.U., Welsh, S.J., Haydon, A., Sandhu, S., Mangana, J., McQuade, J.L., Ascierto, P.A., Zimmer, L., Johnson, D.B., Arance, A., Lorigan, P., Lebbé, C., Carlino, M.S., Sullivan, R.J., Long, G.V., Menzies, A.M.
Publikováno v:
In Annals of Oncology July 2021 32(7):917-925
Autor:
Mallardo D; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy., Fordellone M; Mental and Physical Health and Preventive Medicine, Medical Statistics Unit, University of Campania 'Luigi Vanvitelli', 81100 Naples, Italy., White A; NanoString Technologies, Seattle, WA 98109, USA., Vowinckel J; Biognosys AG, 8952 Schlieren, Switzerland., Bailey M; NanoString Technologies, Seattle, WA 98109, USA., Sparano F; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy., Sorrentino A; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy., Mallardo M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy., Facchini BA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy., De Filippi R; Department of Clinical Medicine and Surgery, Università degli Studi di Napoli Federico II, 80138 Naples, Italy., Ferrara G; Department of Pathology and Cytopathology, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy., Vanella V; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy., Beeler K; Biognosys AG, 8952 Schlieren, Switzerland., Chiodini P; Mental and Physical Health and Preventive Medicine, Medical Statistics Unit, University of Campania 'Luigi Vanvitelli', 81100 Naples, Italy., Cesano A; NanoString Technologies, Seattle, WA 98109, USA., Warren S; NanoString Technologies, Seattle, WA 98109, USA., Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', 80131 Napoli, Italy.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Aug 28; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 28.
Autor:
Fletcher K; Vanderbilt University School of Medicine, Nashville, USA. Electronic address: kylie.a.fletcher@vanderbilt.edu., Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Roma, Italy; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom., Ganta T; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kankaria R; Vanderbilt University School of Medicine, Nashville, USA., Song H; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA., Ye F; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA., Irlmeier R; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA., Debnath N; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Saeed A; Division of Hematology & Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Radford M; University of Iowa Healthcare, Iowa City, IA, USA., Alahmadi A; Case Western Reserve University, Division of Hematology & Oncology, Cleveland, OH, USA; Ohio State University, The James Comprehensive Cancer Center, Columbus., Diamond A; Case Western Reserve University, Division of Hematology & Oncology, Cleveland, OH, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Hoimes C; Case Western Reserve University, Division of Hematology & Oncology, Cleveland, OH, USA; Duke Cancer Institute, Duke University, Durham, NC, USA., Presley CJ; Ohio State University, The James Comprehensive Cancer Center, Columbus., Owen DH; Ohio State University, The James Comprehensive Cancer Center, Columbus., Abou Alaiwi S; Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, USA., Nassar AH; Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, USA., Lamberti G; Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy., Perrone F; Medical Oncology Unit, University Hospital of Parma and Medicine and Surgery Department, University of Parma, Parma, Italy., Buti S; Medical Oncology Unit, University Hospital of Parma and Medicine and Surgery Department, University of Parma, Parma, Italy., Giusti R; Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy., Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy., Vanella V; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Mallardo D; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Sussman TA; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Galetta D; IRCCS Istituto Tumori Giovanni Paolo II, Medical Thoracic Oncology Unit, Bari, Italy., Kalofonou F; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Daniels E; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Department of Translational Medicine, University of Piemonte Orientale 'A. Avogadro', Novara, Italy., Nebhan C; Intermountain Health, Murray UT, USA., Berg S; Dana-Farber Cancer Institute, Boston, MA, USA., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA., Marron TU; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wang Y; The University of Texas MD Anderson Cancer Center, Houston., Naqash AR; Medical Oncology/TSET Phase 1 Program, Stephenson Cancer Center, University of Oklahoma, Oklahoma City, USA., Johnson DB; Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: douglas.b.johnson@vumc.org.
Publikováno v:
Cancer letters [Cancer Lett] 2024 Aug 01; Vol. 596, pp. 217001. Date of Electronic Publication: 2024 Jun 03.
Autor:
Mallardo D; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Sparano F; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Vitale MG; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Trojaniello C; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Fordellone M; Universitiy of Campania 'Luigi Vanvitelli', 81100, Naples, Italy., Cioli E; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Esposito A; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Festino L; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Mallardo M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Vanella V; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Facchini BA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., De Filippi R; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Meinardi P; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori 'Fondazione Pascale' IRCCS, Naples, Italy., Ottaviano M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori 'Fondazione Pascale' IRCCS, Naples, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy. p.ascierto@istitutotumori.na.it.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Jun 08; Vol. 73 (8), pp. 160. Date of Electronic Publication: 2024 Jun 08.
Autor:
Jacques SK; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, Australia., McKeown J; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Grover P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Johnson DB; Vanderbilt University Medical Centre, Nashville, TN, USA., Zaremba A; Department of Dermatology, Venereology and Allergology, University Hospital Essen, Essen, Germany., Dimitriou F; Department of Dermatology, University Hospital of Zurich and Faculty of Medicine, University of Zürich, Zurich, Switzerland., Weiser R; MD Anderson Cancer Center, Houston, TX, USA., Farid M; National Cancer Centre, Singapore., Namikawa K; Department of Dermatologic Oncology, National Cancer Center, Tokyo, Japan., Sullivan RJ; Massachusetts General Hospital, Harvard University, Boston, MA, USA., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Lebbe C; Université Paris Cite,AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France., Hamid O; The Angeles Clinic, A Cedars-Sinai Affiliate, Los Angeles, CA, USA., Zager JS; Department of Cutaneous Oncology, Moffit Cancer Center, Tampa, FL, USA., Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Neyns B; Universitair Ziekenhuis Brussel, Brussels, Belgium., Nakamura Y; Department of Skin Oncology/Dermatology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan., Robert C; Institute Gustave Roussy and Paris Saclay University, Villejuif Cedex, France., Mehnert J; NYU Langone, New York City, NY, USA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Bhave P; Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Park B; Vanderbilt University Medical Centre, Nashville, TN, USA., Zimmer L; Department of Dermatology, Venereology and Allergology, University Hospital Essen, Essen, Germany., Mangana J; Department of Dermatology, University Hospital of Zurich and Faculty of Medicine, University of Zürich, Zurich, Switzerland., Mooradian M; Massachusetts General Hospital, Harvard University, Boston, MA, USA., Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Allayous C; Université Paris Cite,AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France., Glitza Oliva IC; MD Anderson Cancer Center, Houston, TX, USA., Mehmi I; The Angeles Clinic, A Cedars-Sinai Affiliate, Los Angeles, CA, USA., Depalo D; Department of Cutaneous Oncology, Moffit Cancer Center, Tampa, FL, USA., Wicky A; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Schwarze JK; Universitair Ziekenhuis Brussel, Brussels, Belgium., Roy S; Institute Gustave Roussy and Paris Saclay University, Villejuif Cedex, France., Boatwright C; NYU Langone, New York City, NY, USA., Vanella V; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Carlino MS; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Electronic address: matteo.carlino@sydney.edu.au.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113563. Date of Electronic Publication: 2024 Jan 22.
Autor:
Mallardo, D., Fordellone, M., Bailey, M., White, A., Simeone, E., Festino, L., Vanella, V., Trojaniello, C., Vitale, M.G., Ottaviano, M., Sparano, F., Facchini, B.A., Cavalcanti, E., Church, S., Caracò, C., Cesano, A., Warren, S., Chiodini, P., Ascierto, P.A.
Publikováno v:
In EJC Skin Cancer 2024 2 Supplement 1
Autor:
Granata V; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy. v.granata@istitutotumori.na.it., Simonetti I; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy., Fusco R; Medical Oncology Division, Igea SpA, Naples, Italy., Setola SV; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy., Izzo F; Hepatobiliary Surgical Oncology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia',, Via Mariano Semmola, Naples, Italy., Scarpato L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Vanella V; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Festino L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Simeone E; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Ascierto PA; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Petrillo A; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy.
Publikováno v:
La Radiologia medica [Radiol Med] 2022 Aug; Vol. 127 (8), pp. 899-911. Date of Electronic Publication: 2022 Jul 14.
Autor:
Goodman RS; Vanderbilt University School of Medicine, Nashville, TN, USA., Di Guardo L; Department of Medical Oncology, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Milano Province, Italy., Maurichi A; Department of Medical Oncology, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Milano Province, Italy., Kirwin B; Department of Medical Oncology, Melanoma Institute of Australia, The University of Sydney, Mater and Royal North Shore Hospitals, Sydney, NSW, Australia., Khattak A; Department of Medical Oncology, Fiona Stanley Hospital, Edith Cowan University, Perth, WA, Australia., Vanella V; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Napoli Province, Italy., Lee J; Department of Medical Oncology, Blacktown and Westmead Hospitals, Sydney, New South Wales, Australia., Lawless A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Czapla J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Spagnoletti A; Department of Medical Oncology, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Milano Province, Italy., Ambrosini M; Department of Medical Oncology, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Milano Province, Italy., Livingstone E; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, North Rhine Westphalia, Germany., Long GV; Department of Medical Oncology, Melanoma Institute of Australia, The University of Sydney, Mater and Royal North Shore Hospitals, Sydney, NSW, Australia., Sullivan RJ; Division of Hematology and Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Carlino MS; Department of Medical Oncology, Blacktown and Westmead Hospitals, Sydney, New South Wales, Australia; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia., Atkinson V; University of Queensland, Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, QLD, Australia., Trojanello C; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Napoli Province, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Napoli Province, Italy., Schadendorf D; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, North Rhine Westphalia, Germany., Warburton L; Department of Medical Oncology, Fiona Stanley Hospital, Edith Cowan University, Perth, WA, Australia., Menzies AM; Department of Medical Oncology, Melanoma Institute of Australia, The University of Sydney, Mater and Royal North Shore Hospitals, Sydney, NSW, Australia., Santinami M; Department of Medical Oncology, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Milano Province, Italy., Johnson DB; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: douglas.b.johnson@vumc.org.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 194, pp. 113354. Date of Electronic Publication: 2023 Sep 22.
Autor:
Choucair K; Barbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA., Nebhan C; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA., Cortellini A; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London SW7 2BX, UK.; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy., Hentzen S; Department of Medicine, Kansas University Medical Center, Kansas City, KS 66211, USA., Wang Y; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Liu C; Department of Internal Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Giusti R; Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, 00189 Rome, Italy., Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 71013 Rome, Italy., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy., Vanella V; Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy., Galetta D; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Catino A; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Al-Bzour N; UPMC Hillman Cancer Center, Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, PA 15232, USA., Saeed A; Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT 05401, USA., Cavalcante L; Novant Health Cancer Institute, Charlotte, NC 28204, USA., Pizzutilo P; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Genova C; UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.; Dipartimento di Medicina Interna e Specialità Mediche, Università degli Studi di Genova, 16126 Genova, Italy., Bersanelli M; Medical Oncology Unit, University Hospital of Parma, 43125 Parma, Italy., Buti S; Medicine and Surgery Department, University of Parma, 43121 Parma, Italy., Johnson DB; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA., Fulgenzi CAM; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London SW7 2BX, UK.; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy., Pinato DJ; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London SW7 2BX, UK., Radford M; Department of Medicine, Kansas University Medical Center, Kansas City, KS 66211, USA., Kim C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA., Naqash AR; Medical Oncology/Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73019, USA., Saeed A; UPMC Hillman Cancer Center, Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, PA 15232, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Oct 19; Vol. 15 (20). Date of Electronic Publication: 2023 Oct 19.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.